The Advisory Team at SilkTech Biopharmaceuticals provides strategic guidance and expert insights to support the development and commercialization of silk-based anti-inflammatory therapies, with a primary focus on Dry Eye Disease. Comprised of seasoned professionals, they offer critical advice on clinical trials, regulatory compliance, market positioning, and potential partnerships.
View all